Ensysce Biosciences Ratios (2020-2025) | ENSC

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -3.43%-75.03%-322.05%-348.04%-297.61%-1,408.33%-123.48%-798.85%-3,418.77%-2,208.04%-436.19%-324.55%-467.70%-623.58%-679.66%-1,011.06%-1,090.78%18.74%-275.17%-149.37%-127.87%-759.97%
EBIT Margin 7.62%-48.91%-262.51%-209.23%-92.82%-1,406.28%-122.71%-796.36%-3,400.56%-2,206.30%-432.57%-324.36%-467.70%-621.83%-612.72%-602.82%-1,075.62%18.86%-274.34%-149.08%-127.64%-758.68%
EBITDA Margin 7.62%-48.91%-262.51%-209.23%-92.82%-1,406.28%-122.71%-796.36%-3,400.56%-2,206.30%-432.57%-324.36%-467.70%-621.83%-612.72%-602.82%-1,075.62%18.86%-274.34%-149.08%-127.64%-758.68%
Operating Margin 7.62%-48.91%-262.51%-209.23%-92.82%-1,406.28%-122.71%-796.36%-3,400.56%-2,206.30%-432.57%-324.36%-467.70%-621.83%-612.72%-602.82%-1,075.62%18.86%-274.34%-149.08%-127.64%-758.68%
Net Margin -3.43%189.76%51.38%-362.26%-210.46%-1,429.32%-662.88%-276.35%-3,855.62%-3,543.07%-385.21%-278.13%-455.88%-617.75%-680.40%-1,019.48%-1,082.41%19.36%-273.42%-147.42%-126.39%-756.26%
FCF Margin -17.88%-18.48%-128.18%-206.38%-29.77%-318.53%-230.41%-569.89%-2,140.30%-2,403.54%-229.91%-456.78%-633.79%-519.69%-349.86%-1,114.87%-1,270.59%-29.84%-58.61%-129.37%-197.37%-378.46%
Efficiency
Assets Average 37.51M13.35M6.82M9.46M13.07M14.39M10.16M8.12M7.09M4.90M2.96M6.09M7.49M5.10M5.09M4.38M
Equity Average 5.00M5.00M-0.83M2.51M-4.27M-3.38M0.30M-3.61M-5.23M-1.93M0.42M4.36M5.31M3.38M3.22M2.30M
Invested Capital 5.00M5.00M5.00M-6.66M5.41M-0.39M-8.16M1.39M-0.80M-5.62M-4.03M0.17M1.49M-0.65M1.81M6.91M3.71M3.05M3.39M1.20M
Asset Utilization Ratio 0.450.240.270.270.360.340.360.550.750.730.701.221.461.03
Leverage & Solvency
Interest Coverage Ratio 0.69-1.87-4.41-1.51-0.45-684.78-160.71-319.74-186.74-0.00M-119.56-0.00M-353.94-9.15-1.48-70.94158.69-332.60-510.25-553.96-587.39
Debt to Equity 0.110.110.11-5.49-0.541.14-0.45-0.34-0.03
Debt Ratio 0.010.040.040.220.270.130.050.270.02
Equity Ratio 0.080.370.38-18.930.59-0.04-0.500.11-0.10-0.77-0.680.040.46-0.240.650.740.660.660.610.38
Times Interest Earned 0.69-1.87-4.41-1.51-0.45-684.78-160.71-319.74-186.74-0.00M-119.56-0.00M-353.94-9.15-1.48-70.94158.69-332.60-510.25-553.96-587.39
Valuation
Enterprise Value -0.17M-0.12M-0.05M-0.41M-8.26M-7.13M-12.54M-8.72M-12.40M-4.83M-3.46M-1.73M-1.79M-1.45M-1.37M-4.48M-3.83M-3.38M-2.54M-2.00M
Return Ratios
Return on Sales -0.03%-0.75%-3.22%-3.48%-2.98%-14.08%-1.23%-7.99%-34.19%-22.08%-4.36%-3.25%-4.68%-6.24%-6.80%-10.11%-10.91%0.19%-2.75%-1.49%-1.28%-7.60%
Return on Capital Employed -7.80%5.81%-4.31%-16.09%5.28%10.19%-23.79%29.00%-1.92%-1.27%-2.05%-2.58%-5.33%
Return on Assets -0.30%-2.16%-1.62%-1.74%-3.04%-2.48%-3.43%-4.51%-3.74%-1.30%-1.07%-1.35%-1.31%-2.53%
Return on Equity 2.44%-8.14%4.95%7.41%-103.96%5.57%4.66%11.43%-26.56%-1.82%-1.51%-2.04%-2.07%-4.82%